Reduction of glycemic variability with Degludec insulin in patients with unstable diabetes

INTRODUCTION: Degludec (IDeg) is an ultralong-acting insulin, with stable pharmacodynamic profile which leads to lower fluctuations in glucose levels. The effect of IDeg has not been specifically assessed in patients with unstable diabetes, defined as increased glycemic variability (GV). METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Henao-Carrillo, Diana Cristina, Muñoz, Oscar M., Gómez, Ana M., Rondón, Martín, Colón, Christian, Chica, L., Rubio, Claudia, León-Vargas, Fabián, Calvachi, Maria Alejandra, Perea, Ana María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992319/
https://www.ncbi.nlm.nih.gov/pubmed/29892561
http://dx.doi.org/10.1016/j.jcte.2018.03.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992319/
https://www.ncbi.nlm.nih.gov/pubmed/29892561
http://dx.doi.org/10.1016/j.jcte.2018.03.003

Ejemplares similares